Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Ekaterina Knyazkova
JPM
Ekaterina Knyazkova
J.P. Morgan
Wall Street Analyst
★★★☆☆
#1647
on 13Foresight · ranked by our own returns
25%
Success Rate
-16.4%
Average Return
1 of 4 calls profitable · -28.9% vs benchmark
📈 Across the calls we could measure, roughly 25% of Ekaterina Knyazkova's ratings turned a profit when each position was held for 1 year — averaging -16.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

7 Buy 0 Hold 0 Sell
Ekaterina's Stock Coverage 3 ratings · 2026-06-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
PAHC
Phibro Animal Health
 Jun 12, 2026 BUY Hold
+17.0% avg upside
10 analysts
 — +2.4%
ANIP
ANI Pharmaceuticals
 Sep 24, 2025 BUY Strong Buy
+28.7% avg upside
11 analysts
$115.00
44.75% Upside
 -17.9%
AMPH
Amphastar Pharmaceuticals
 May 12, 2025 HOLD Hold
+42.4% avg upside
11 analysts
$30.00
59.40% Upside
 -11.1%
Ekaterina Knyazkova — Frequently Asked Questions
How accurate are Ekaterina Knyazkova's stock ratings?
Based on the calls 13Foresight could measure, about 25% of Ekaterina's ratings were profitable over a one-year hold, with an average return of -16.4% per rating, or -28.7% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Ekaterina ranked on 13Foresight?
Ekaterina Knyazkova is currently ranked #1647 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Ekaterina cover?
Ekaterina most recently has ratings on PAHC, ANIP, AMPH. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.